
Measles cases in U.S. in 2026?
- ↑500
- 100%
- —
- ↑1k
- 100%
- —
- ↑2k
- 100%
- —
- ↑3k
- 95%
- —
- ↑3.5k
- 92%
- −2.5
- ↑4k
- 64%
- +0.5
- ↑4.5k
- 28%
- +1.0
- ↑5k
- 20%
- —
- ↑7.5k
- 12%
- +0.5
- ↑10k
- 6%
- +0.7
- ↑12.5k
- 5%
- —
Traders currently price "↑500" at 100% for "Measles cases in U.S. in 2026?". Full distribution: ↑500 100%, ↑1k 100%, ↑2k 100%, ↑3k 95%. The market has traded $7.8M in total volume and resolves Dec 31, 2026. As of early August 2026, the CDC has confirmed 2,465 measles cases nationwide—already exceeding the full-year 2025 total of 2,289 and marking the highest annual figure since 1991. Ongoing transmission, concentrated in under-vaccinated communities and fueled by imported cases, has produced dozens of new infections weekly, including a recent surge adding nearly 100 cases. Measles’ basic reproduction number near 12–18 enables rapid spread where immunity gaps exist, with 20% of 2026 cases occurring in children under five. CDC weekly surveillance updates and the ongoing elimination-status review by the agency’s advisory committee represent key near-term data points that could influence market-implied odds on final 2026 totals.
Odds sourced live from Polymarket, refreshed through the day. Prediction-market participation carries risk and may be restricted in your jurisdiction. Informational only — not investment advice.
